drugset / Trial / NCT05476172
The Effect of Dienogest vs. Norethindrone Acetate Treatment in Endometriosis
RandomizedParallel-groupOpen-labelTreatment
Summary
This randomized controlled study aims to investigate the efficiency of medical treatment modalities in endometriosis patients. The study protocol involves two arms. (Dienogest Group and Noretindrone Acetate Group). The patients diagnosed with endometriosis are randomized depending on their protocol ids. The Dienogest group is prescribed 5 mg dienogest per day and neta group is prescribed 5 mg neta per day. The pain scores will be analyzed six months and twelve months after treatment.
Timeline
- Start
- 2021-04-01
- Primary completion
- 2023-05-30
- Completion
- 2023-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dienogest | Small molecule | 2 mg | Oral |
| Comparator | Norethindrone | Unknown | 5 mg | Oral |